account_id none on file
legal_name Abivax S.A.
ticker ABVX
cik 1956827
domain abivax.com
linkedin_company_url https://www.linkedin.com/company/abivax/
entry_point_account_id none on file
name Abivax SA
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 15 executives 9 family 0
why_nownone on file
callsnone on file
filings
for the various populations worldwide, the final geographical spread of the disease, its duration, travel restrictions and social distancing measures in the European Union, the United States and other countries, business closures or disruptions, and the effectiveness of measures taken in those countries to contain and treat the disease.
filing / Mar 23, 2026 / receipt
The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our drug candidates.
filing / Mar 23, 2026 / receipt
pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost containment measures.
filing / Mar 23, 2026 / receipt
We lease an additional 279 square meters of office space in Boston, Massachusetts. We believe our existing facilities meet our current needs.
filing / Mar 23, 2026 / receipt
represents the full year impact of the build out of our G&A organization (increased headcount and equity-based compensation costs) which started in late 2023 to support the expansion of the company, as well as increased legal and professional fees and other costs associated with operating as a dual-listed public company.
filing / Mar 23, 2026 / receipt
spend driven by the progression of the UC Phase 3 clinical trial, increased headcount to support the expansion of the overall organization, including a newly created sales and marketing department, increased legal and professional fees and other infrastructure costs associated with operating as a dual-listed public company and changes in working capital.
filing / Mar 23, 2026 / receipt
Marc de Garidel .......................... | 68 | Chief Executive Officer and Director
filing / Mar 23, 2026 / receipt
Didier Blondel ............................ | 63 | Executive Vice President, Chief Financial Officer and Board Secretary
filing / Mar 23, 2026 / receipt
Fabio Cataldi ............................... | 59 | Chief Medical Officer
filing / Mar 23, 2026 / receipt
Sylvie Grégoire ........................... | 64 | Board Chair, Independent Director, Chair of the Nomination and Governance Committee, Member of the Audit Committee
filing / Mar 23, 2026 / receipt
June Lee ...................................... | 60 | Independent Director, Chair of the Remuneration Committee, Chair of the Science and Clinical Committee
filing / Mar 23, 2026 / receipt
Troy Ignelzi ................................ | 58 | Independent Director, Chair of the Audit Committee, Member of the Remuneration Committee
filing / Mar 23, 2026 / receipt
executives
| Camilla Soenderby ...................... | Independent Director, Chair of the Commercial Committee, Member of the Remuneration Committee, Member of the Science and Clinical Committee, Member of the Nomination and Governance Committee | - | receipt |
| Corinna zur Bonsen-Thomas ...... | Independent Director, Member of the Audit Committee, Member of Nomination and Governance Committee | - | receipt |
| Didier Blondel ............................ | Executive Vice President, Chief Financial Officer and Board Secretary | receipt | |
| Dominik Höchli .......................... | Independent Director, Member of the Science and Clinical Committee, Member of the Commercial Committee | - | receipt |
| Fabio Cataldi ............................... | Chief Medical Officer | - | receipt |
| June Lee ...................................... | Independent Director, Chair of the Remuneration Committee, Chair of the Science and Clinical Committee | - | receipt |
| Marc de Garidel .......................... | Chief Executive Officer and Director | - | receipt |
| Sylvie Grégoire ........................... | Board Chair, Independent Director, Chair of the Nomination and Governance Committee, Member of the Audit Committee | - | receipt |
| Troy Ignelzi ................................ | Independent Director, Chair of the Audit Committee, Member of the Remuneration Committee | - | receipt |
familynone on file
upcomingnone on file
changesnone on file
mcp_package_hint
slug abivax-sa
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$